Article Details

Lytix Biopharma announces approval to expand the ATLAS-IT-05 study to Europe

Retrieved on: 2022-09-07 09:57:21

Tags for this article:

Click the tags to see associated articles and topics

Lytix Biopharma announces approval to expand the ATLAS-IT-05 study to Europe. View article details on hiswai:

Excerpt

PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company, today announces the regulatory ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up